Clik here to view.
Imricor Collaborates with GE HealthCare in Interventional Cardiac MRI
MINNEAPOLIS Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has...
View ArticleClik here to view.
Latest Clinical Data of InnoCare’s Gunagratinib Presented at 2023 ASCO GI
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the development of therapies for cancer and autoimmune diseases, announced today that the latest...
View ArticleClik here to view.
PHCの遠隔医療システム「Teladoc HEALTH」がシェアメディカルのデジタル聴診デバイス「ネクステート」と接続 ～...
東京 （ビジネスワイヤ） — PHC株式会社メディコム事業部（本社：東京都港区、代表取締役社長：中村 伸朗、以下、「PHC」）と株式会社シェアメディカル（本社：東京都千代田区、代表取締役CEO：峯 啓真、以下、「シェアメディカル」）は、このたび、遠隔医療領域における事業提携を通じ、遠隔医療システム「Teladoc...
View ArticleClik here to view.
ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients...
TOKYO & MUNICH Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as monotherapy indicated for the...
View ArticleClik here to view.
Qurient Announces Dosing of First Patient in Q702 in Combination with...
SEOUL, South Korea Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the first patient has been dosed in the Phase 1b/2 clinical study of Q702 in...
View ArticleClik here to view.
2023年日本奖获奖者名单揭晓
东京 (美国商业资讯)–日本奖基金会(The Japan Prize Foundation)于日本标准时间2023年1月30日13:00公布了2023年日本奖的获奖者名单。Masataka Nakazawa教授和Kazuo Hagimoto先生共同获得电子、信息和通信领域的日本奖，Gero Miesenböck教授和Karl Deisseroth教授共同获得生命科学领域的日本奖。...
View ArticleClik here to view.
New Promega Chemistry Will Enable Forensic DNA Labs to Solve More Challenging...
MADISON, Wis. New chemistry for DNA analysis will empower forensic laboratories to overcome common challenges including degraded and contaminated samples. PowerPlex® 35GY System, launched today by...
View ArticleClik here to view.
Shin-Nihon Public Affairs Announces Yasuhisa Shiozaki to join as Special Advisor
TOKYO Shin-Nihon Public Affairs Co. (Head Office: Tokyo; President: Yasushi Kohara) today announced Mr. Yasuhisa Shiozaki as special advisor. Mr. Shiozaki is a former Chief Cabinet Secretary, and...
View ArticleClik here to view.
BeiGene to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two...
View ArticleClik here to view.
Ronovo Surgical Emerges with $50M+ to Accelerate Paradigm Shift Towards...
SHANGHAI One of the fastest growing companies in the global robotic and digital surgery space, Ronovo Surgical recently announced successful closing of new financing to accelerate its vision of...
View ArticleClik here to view.
TURALIO® New Dosing Regimen Now Available in the U.S. for Certain Patients...
BASKING RIDGE, N.J. Daiichi Sankyo (TSE: 4568) today announced that the new dosing regimen for TURALIO® (pexidartinib) is now available in the U.S. for the treatment of adult patients with...
View ArticleClik here to view.
武田薬品工業: パイプラインの進展と2つのターゲットを絞った取得案件により長期的成長に向け加速、2022年度第3四半期も力強い業績を達成
大阪 （ビジネスワイヤ） – 武田薬品工業株式会社（TOKYO:4502/NYSE:TAK）は、本日、2022年度第3四半期の業績を公表しましたのでお知らせします。 当社チーフ フィナンシャル オフィサーのコスタ・サルウコス（Costa Saroukos）は次のように述べています。...
View ArticleClik here to view.
Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two...
OSAKA, Japan Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the third quarter of fiscal year 2022 (period ended December 31, 2022). Takeda chief financial officer, Costa...
View ArticleClik here to view.
Kyocera Develops New “Contactless Intelligent Millimeter-Wave Sensing System”
KYOTO, Japan Kyocera Corporation (President: Hideo Tanimoto) today announced it has developed a new “contactless intelligent millimeter-wave sensing system”. The system includes a high-precision,...
View ArticleClik here to view.
New Talk About It Resources Aim to Accelerate Integration of Mental Health...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, has released a report highlighting the challenges cancer...
View ArticleClik here to view.
Exscientia宣布对百时美施贵宝许可的PKC Theta抑制剂EXS4318进行首次人体研究
英格兰牛津 (美国商业资讯)–EXS4318 (’4318)是一种由Exscientia plc (Nasdaq: EXAI)设计并由百时美施贵宝(Bristol Myers...
View ArticleClik here to view.
U.S. FDA Approves Takeda’s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for...
View ArticleClik here to view.
Dentalis Animal Health任命顾问委员会
蒙特利尔 (美国商业资讯)–致力于为伴侣动物提供口腔保健服务的公司Dentalis Animal Health宣布任命其顾问委员会。 Michael Kelly Michael...
View ArticleClik here to view.
エクセンシア、ブリストル マイヤーズ スクイブにライセンスしたPKCシータ阻害剤EXS4318のヒト初回投与試験の開始を発表
英オックスフォード （ビジネスワイヤ） — エクセンシア（Nasdaq: EXAI）は本日、当社が精密設計し、2021年8月にブリストル マイヤーズ スクイブにライセンスした化合物EXS4318（’4318）の第1相臨床試験が米国で開始されたと発表しました。本化合物は、免疫・炎症領域（I&I）の適応症で開発が進行中です。ブリストル マイヤーズ...
View ArticleClik here to view.
Phase II Study of Orelabrutinib in Patients with R/R CLL/SLL Published by...
BEIJING American Journal of Hematology recently published the phase 2 study result of BTK (Bruton Tyrosine Kinase) inhibitor orelabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia...
View Article